Fisher & Paykel Healthcare | FPH - Selling And Administration Expenses

Stock Price
33.72
Daily Change
2.06 6.51%
Monthly
0.75%
Yearly
8.18%
Q1 Forecast
31.05

Fisher & Paykel Healthcare reported NZD285.5M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Cochlear AUD 234.95M 235.05M Jun/2025
CSL USD 727M 453M Jun/2025
Nanosonics AUD 26.85M 23.41M Jun/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Somnomed AUD 19.5M 353.23K Jun/2023
Sonic Healthcare AUD 2.52B 2.46B Dec/2024